Delayed 5-day change 1st Jan Change
- USD -.--% Intraday chart for ReGen Biologics Inc. -.--% -

Valuation: ReGen Biologics Inc.

Market Cap 1.17M 1.05M 978K 889K 1.67M 114M 1.69M 11.76M 4.59M 57.73M 4.41M 4.31M 186M P/E 2007
-0.9x
P/E 2008 -1.66x
Enterprise Value 11.46M 10.24M 9.55M 8.68M 16.34M 1.11B 16.46M 115M 44.84M 564M 43.02M 42.09M 1.81B EV / Sales 2007
14x
EV / Sales 2008 22.7x
Free-Float
100%
Yield 2007 *
-
Yield 2008 -
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 25
+0.58%-0.10%-25.78%+1.91% 170B
-1.81%-0.90%-13.04%+12.34% 111B
-1.01%+0.00%-25.41%+3.59% 107B
-0.03%+0.72%-46.94%-10.61% 75.95B
+0.28%+5.66%+2.77%+72.56% 60.37B
-0.42%+6.09%+10.91%+65.61% 53.53B
-0.08%+0.65%-6.42%-31.35% 49.11B
-1.70%-2.97%-19.23%+13.61% 40.6B
+1.09%-2.31%+27.67%+1.30% 31.47B
Average +0.09%+0.97%-10.61%+14.33% 69.9B
Weighted average by Cap. +0.27%+0.85%-16.57%+11.76%

Financials

2007 2008
Net sales 986K 881K 822K 747K 1.41M 95.38M 1.42M 9.88M 3.86M 48.51M 3.7M 3.62M 156M 1.37M 1.23M 1.15M 1.04M 1.96M 133M 1.97M 13.76M 5.38M 67.6M 5.16M 5.05M 217M
Net income -10.38M -9.27M -8.65M -7.86M -14.8M -1B -14.91M -104M -40.61M -511M -38.96M -38.11M -1.64B -9.95M -8.89M -8.3M -7.53M -14.19M -963M -14.3M -99.68M -38.94M -490M -37.36M -36.55M -1.57B
Net Debt 4.09M 3.66M 3.41M 3.1M 5.84M 396M 5.88M 41M 16.02M 201M 15.37M 15.03M 647M 10.28M 9.19M 8.57M 7.79M 14.67M 995M 14.78M 103M 40.25M 506M 38.61M 37.78M 1.63B
Logo ReGen Biologics Inc.
Regen Biologics Inc (ReGen) is a United States-based development stage orthopedic products company. The Company develops, manufactures and markets tissue growth and repair products for United States and global markets. The Company's collagen matrix technology includes applications in orthopedics, general surgery, spine, cardiovascular and drug delivery. Some of these applications are marketable while others are in various stages of development. Its approved product using its collagen matrix technology is the Menaflex collagen meniscus implant device (also known as the CMI), which is marketed for sale in the European Union (EU), Switzerland, Turkey, and the Republic of South Africa, through the Company’s subsidiary, ReGen Biologics AG.
Employees
-
  1. Stock Market
  2. Stocks
  3. RGBOQ Stock